Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus.
Karnell JL, Wu Y, Mittereder N, Smith MA, Gunsior M, Yan L, Casey KA, Henault J, Riggs JM, Nicholson SM, Sanjuan MA, Vousden KA, Werth VP, Drappa J, Illei GG, Rees WA, Ratchford JN; VIB7734 Trial Investigators. Karnell JL, et al. Among authors: nicholson sm. Sci Transl Med. 2021 May 26;13(595):eabf8442. doi: 10.1126/scitranslmed.abf8442. Sci Transl Med. 2021. PMID: 34039741 Clinical Trial.
Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring.
Nicholson SM, Carlesso G, Cheng LI, Cook H, DaCosta K, Leininger J, McKeever K, Scott SW, Taylor D, Streicher K, Eck S, Reed M, Faggioni R, Herbst R, Dixit R, Ryan PC. Nicholson SM, et al. Reprod Toxicol. 2017 Dec;74:116-133. doi: 10.1016/j.reprotox.2017.08.018. Epub 2017 Sep 13. Reprod Toxicol. 2017. PMID: 28916434
Talaromycosis (Penicilliosis) in a Cynomolgus Macaque.
Iverson WO, Karanth S, Wilcox A, Pham CD, Lockhart SR, Nicholson SM. Iverson WO, et al. Among authors: nicholson sm. Vet Pathol. 2018 Jul;55(4):591-594. doi: 10.1177/0300985818758468. Epub 2018 Feb 14. Vet Pathol. 2018. PMID: 29444633
Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.
Luo H, Li Y, Robbins D, Wang SC, Xi G, Cox M, Nicholson SM, Wei C, Pabst TM, Wang WK. Luo H, et al. Among authors: nicholson sm. Biotechnol Prog. 2021 May;37(3):e3119. doi: 10.1002/btpr.3119. Epub 2021 Jan 6. Biotechnol Prog. 2021. PMID: 33373106 Free PMC article.
A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties.
Nyborg AC, Ward C, Zacco A, Chacko B, Grinberg L, Geoghegan JC, Bean R, Wendeler M, Bartnik F, O'Connor E, Gruia F, Iyer V, Feng H, Roy V, Berge M, Miner JN, Wilson DM, Zhou D, Nicholson S, Wilker C, Wu CY, Wilson S, Jermutus L, Wu H, Owen DA, Osbourn J, Coats S, Baca M. Nyborg AC, et al. PLoS One. 2016 Dec 21;11(12):e0167935. doi: 10.1371/journal.pone.0167935. eCollection 2016. PLoS One. 2016. PMID: 28002433 Free PMC article.
Logistics for achieving delivery: A secondary analysis of the home induction randomised controlled trial.
Nicholson SM, Flood K, Dicker P, Molphy ZE, Smith OT, Oprescu CI, Wall EM, El Nimr SN, Shanahan IM, Kennedy BJ, Daly RV, Geary MP, Gannon G, Looi C, Cleary BJ, Fernandez E, Malone FD. Nicholson SM, et al. Eur J Obstet Gynecol Reprod Biol. 2024 Dec 5;305:56-61. doi: 10.1016/j.ejogrb.2024.11.043. Online ahead of print. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 39647250
Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial.
Nicholson SM, Flood K, Dicker P, Molphy ZE, Smith OT, Oprescu CI, Wall EM, El Nimr SN, Shanahan IM, Kennedy BJ, Daly RV, Gannon G, Looi C, Fernandez E, Malone FD. Nicholson SM, et al. EClinicalMedicine. 2024 Jul 17;74:102741. doi: 10.1016/j.eclinm.2024.102741. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39114276 Free PMC article.
A randomised open-label trial to assess outpatient induction of labour (HOMEIND) and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks' gestation in normal risk nulliparous women: study protocol for a randomised controlled trial.
Nicholson SM, Smith O, Hatt S, Molphy Z, Dicker P, Flood K, Malone F. Nicholson SM, et al. Trials. 2023 Feb 23;24(1):135. doi: 10.1186/s13063-023-07174-7. Trials. 2023. PMID: 36814336 Free PMC article.
29 results